Aqr Capital Management LLC Cyma Bay Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $124,266 - $240,760	-9,839 Reduced 30.64%	22,270 $526,000
Q3 2023 Nov 14, 2023	SELL	$10.86 - $17.62 $90,985 - $147,620	-8,378 Reduced 20.69%	32,109 $478,000
Q2 2023 Aug 14, 2023	BUY	$7.47 - $10.95 $302,437 - $443,332	40,487 New	40,487 $443,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $4.6 $34,166 - $48,658	-10,578 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.47 - $4.42 $36,705 - $46,754	10,578 New	10,578 $39,000
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $381,634 - $590,947	-90,221 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.73 - $9.03 $516,966 - $814,695	90,221 New	90,221 $518,000
Q1 2020 May 15, 2020	SELL	$1.25 - $2.02 $22,918 - $37,036	-18,335 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $24,385 - $108,726	18,335 New	18,335 $36,000
Q1 2019 May 14, 2019	SELL	$8.16 - $13.42 $179,462 - $295,146	-21,993 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$6.54 - $11.74 $121,663 - $218,399	-18,603 Reduced 45.82%	21,993 $173,000
Q3 2018 Nov 15, 2018	BUY	$10.88 - $14.52 $76 - $101	7 Added 0.02%	40,596 $450,000
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $432,678 - $583,669	40,589 New	40,589 $545,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.